Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of ulinastatin-containing pharmaceutical composition to preparation of medicine for treating carcinoma of gall-bladder

A technology of ulinastatin and its composition, which is applied in the field of preparation of drugs for treating gallbladder cancer, can solve problems such as no gallbladder cancer has been found, and achieve remarkable curative effect and low toxic and side effects

Active Publication Date: 2016-10-12
GUANGDONG TECHPOOL BIO-PHARMA CO LTD
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After searching, there is no relevant research on the pharmaceutical composition of ulinastatin and β-escin sodium in the treatment of gallbladder cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Ulinastatin

[0017] Preparation process: Take prescription amount of ulinastatin and β-escin sodium, dissolve in 500ml 0.9% physiological saline injection, filter, pot, and sterilize at 100°C for 30 minutes to obtain the product.

Embodiment 2

[0019] Ulinastatin

[0020] Preparation process: Take prescription amount of ulinastatin and β-escin sodium, dissolve in 500ml 0.9% physiological saline injection, filter, pot, and sterilize at 100°C for 30 minutes to obtain the product.

Embodiment 3

[0022] Ulinastatin

[0023] Preparation process: Take the prescribed amount of ulinastatin and β-escin sodium, add 20 grams of mannitol to dissolve, adjust the pH to neutral, add water for injection to 2000 ml, add sodium chloride to adjust isotonicity, and filter aseptically , packed in 1000 vials, and freeze-dried under aseptic conditions.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of medical technology and particularly discloses application of an ulinastatin-containing pharmaceutical composition to preparation of a medicine for treating carcinoma of the gall-bladder. The pharmaceutical composition comprises ulinastatin and beta-aescin natrum. Animal tests verify that the pharmaceutical composition can play an obvious inhibition function on human gall-bladder carcinoma nude-mouse transplanted tumor, is low in toxic and side effect and high in security and can serve as the medicine for treating carcinoma of the gall-bladder.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically discloses the use of a pharmaceutical composition containing ulinastatin in the preparation of medicines for treating gallbladder cancer. Background technique [0002] Gallbladder cancer (carcinoma of the gall-blader) occupies the first place among gallbladder malignant tumors, and other types include sarcoma, carcinoid, primary malignant melanoma, and giant cell adenocarcinoma. Primary gallbladder carcinoma is relatively rare clinically, and has not attracted people's attention for a long time. According to domestic textbook reports, it only accounts for about 1% of all cancers. Due to the extensive development of imaging examinations such as B-ultrasound and CT, gallbladder cancer has been gradually recognized and the detection rate has increased. However, the incidence of gallbladder cancer has obvious regional differences, and the incidence of gallbladder cancer patients is...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/57A61K9/19A61K9/08A61P35/00A61K31/704
Inventor 孙明晖李翰明赵菁宋建东
Owner GUANGDONG TECHPOOL BIO-PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com